Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Toxic Optic Neuropathy
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Toxic Optic Neuropathy
Tree Number(s)
C10.292.200.750.500
C10.292.700.475.500
C10.900.300.218.550.500
C11.640.530.500
C23.550.877
C25.100.937
C26.733.902
G01.750.748.500.902
Unique ID
D000081028
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000081028
Scope Note
Damage to the eye or its function (e.g.,
VISUAL IMPAIRMENT
) due to
OPTIC NERVE
damage secondary to toxic substances such as drugs used in
CHEMOTHERAPY
;
IMMUNOTHERAPY
; or
RADIATION
.
Entry Term(s)
Ocular Toxicity
Previous Indexing
Eye Injuries (1964-2019)
Vision Disorders/chemically induced (1971-2019)
Public MeSH Note
2020
History Note
2020
Date Established
2020/01/01
Date of Entry
2019/07/08
Revision Date
2019/07/01
Allowable Qualifiers
blood (BL)
cerebrospinal fluid (CF)
classification (CL)
complications (CO)
diagnosis (DI)
diagnostic imaging (DG)
diet therapy (DH)
drug therapy (DT)
economics (EC)
enzymology (EN)
epidemiology (EP)
ethnology (EH)
etiology (ET)
genetics (GE)
history (HI)
immunology (IM)
metabolism (ME)
microbiology (MI)
mortality (MO)
nursing (NU)
parasitology (PS)
pathology (PA)
physiopathology (PP)
prevention & control (PC)
psychology (PX)
radiotherapy (RT)
rehabilitation (RH)
surgery (SU)
therapy (TH)
urine (UR)
veterinary (VE)
virology (VI)
Nervous System Diseases [C10]
Cranial Nerve Diseases [C10.292]
Cranial Nerve Injuries [C10.292.200]
Optic Nerve Injuries [C10.292.200.750]
Toxic Optic Neuropathy [C10.292.200.750.500]
Nervous System Diseases [C10]
Cranial Nerve Diseases [C10.292]
Optic Nerve Diseases [C10.292.700]
Optic Nerve Injuries [C10.292.700.475]
Toxic Optic Neuropathy [C10.292.700.475.500]
Nervous System Diseases [C10]
Trauma, Nervous System [C10.900]
Craniocerebral Trauma [C10.900.300]
Cranial Nerve Injuries [C10.900.300.218]
Optic Nerve Injuries [C10.900.300.218.550]
Toxic Optic Neuropathy [C10.900.300.218.550.500]
Eye Diseases [C11]
Optic Nerve Diseases [C11.640]
Optic Nerve Injuries [C11.640.530]
Toxic Optic Neuropathy [C11.640.530.500]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Acantholysis [C23.550.035]
Arrhythmias, Cardiac [C23.550.073]
Ascites [C23.550.081]
Atrial Remodeling [C23.550.113]
Azotemia [C23.550.145]
Cardiotoxicity [C23.550.161]
Channelopathies [C23.550.177]
Chromosome Aberrations [C23.550.210]
Death [C23.550.260]
Dehydration [C23.550.274]
Delayed Graft Function [C23.550.277]
Disease [C23.550.288]
Disease Attributes [C23.550.291]
Dysbiosis [C23.550.308]
Emphysema [C23.550.325]
Extravasation of Diagnostic and Therapeutic Materials [C23.550.340]
Femoracetabular Impingement [C23.550.347]
Fibrosis [C23.550.355]
Frailty [C23.550.359]
Genomic Instability [C23.550.362]
Gliosis [C23.550.369]
Granuloma [C23.550.382]
Granulomatosis, Orofacial [C23.550.384]
Growth Disorders [C23.550.393]
Hemolysis [C23.550.403]
Hemorrhage [C23.550.414]
Hyperammonemia [C23.550.421]
Hyperamylasemia [C23.550.425]
Hyperbilirubinemia [C23.550.429]
Hyperplasia [C23.550.444]
Hyperuricemia [C23.550.449]
Hypovolemia [C23.550.455]
Inflammation [C23.550.470]
Intraoperative Complications [C23.550.505]
Ischemia [C23.550.513]
Leukoaraiosis [C23.550.522]
Leukocytosis [C23.550.526]
Lithiasis [C23.550.537]
Long Term Adverse Effects [C23.550.543]
Malacoplakia [C23.550.548]
Menstruation Disturbances [C23.550.568]
Metaplasia [C23.550.589]
Muscle Weakness [C23.550.695]
Myotoxicity [C23.550.706]
Necrosis [C23.550.717]
Neointima [C23.550.722]
Neoplastic Processes [C23.550.727]
Nerve Degeneration [C23.550.737]
Ochronosis [C23.550.744]
Ossification, Heterotopic [C23.550.751]
Ototoxicity [C23.550.753]
Pigmentation Disorders [C23.550.755]
Polydipsia [C23.550.759]
Postoperative Complications [C23.550.767]
Protein Aggregation, Pathological [C23.550.770]
Respiratory Aspiration [C23.550.773]
Retropneumoperitoneum [C23.550.794]
Sclerosis [C23.550.823]
Shock [C23.550.835]
Teratogenesis [C23.550.863]
Toxic Optic Neuropathy [C23.550.877]
Ulcer [C23.550.891]
Vascular Remodeling [C23.550.918]
Yang Deficiency [C23.550.945]
Yin Deficiency [C23.550.972]
Chemically-Induced Disorders [C25]
Drug-Related Side Effects and Adverse Reactions [C25.100]
Akathisia, Drug-Induced [C25.100.249]
Anticholinergic Syndrome [C25.100.311]
Cardiotoxicity [C25.100.389]
Chemotherapy-Related Cognitive Impairment [C25.100.429]
Drug Hypersensitivity [C25.100.468]
Chemical and Drug Induced Liver Injury [C25.100.562]
Ototoxicity [C25.100.656]
Dyskinesia, Drug-Induced [C25.100.750]
Injection Site Reaction [C25.100.781]
Metabolic Side Effects of Drugs and Substances [C25.100.812]
Myotoxicity [C25.100.828]
Propofol Infusion Syndrome [C25.100.844]
Serotonin Syndrome [C25.100.875]
Toxic Optic Neuropathy [C25.100.937]
Wounds and Injuries [C26]
Radiation Injuries [C26.733]
Abnormalities, Radiation-Induced [C26.733.031]
Acute Radiation Syndrome [C26.733.188]
Cardiotoxicity [C26.733.266]
Leukemia, Radiation-Induced [C26.733.345]
Myotoxicity [C26.733.411]
Neoplasms, Radiation-Induced [C26.733.476]
Osteoradionecrosis [C26.733.579]
Ototoxicity [C26.733.650]
Radiation Fibrosis Syndrome [C26.733.685]
Radiation Injuries, Experimental [C26.733.720]
Radiation Pneumonitis [C26.733.762]
Radiodermatitis [C26.733.804]
Toxic Optic Neuropathy [C26.733.902]
Physical Phenomena [G01]
Radiation [G01.750]
Radiation Exposure [G01.750.748]
Radiation Injuries [G01.750.748.500]
Abnormalities, Radiation-Induced [G01.750.748.500.031]
Acute Radiation Syndrome [G01.750.748.500.188]
Cardiotoxicity [G01.750.748.500.266]
Leukemia, Radiation-Induced [G01.750.748.500.345]
Myotoxicity [G01.750.748.500.411]
Neoplasms, Radiation-Induced [G01.750.748.500.476]
Osteoradionecrosis [G01.750.748.500.579]
Ototoxicity [G01.750.748.500.650]
Radiation Fibrosis Syndrome [G01.750.748.500.685]
Radiation Injuries, Experimental [G01.750.748.500.720]
Radiation Pneumonitis [G01.750.748.500.762]
Radiodermatitis [G01.750.748.500.804]
Toxic Optic Neuropathy [G01.750.748.500.902]
Expand All
Collapse All
Toxic Optic Neuropathy
Preferred
Concept UI
M000649533
Scope Note
Damage to the eye or its function (e.g.,
VISUAL IMPAIRMENT
) due to
OPTIC NERVE
damage secondary to toxic substances such as drugs used in
CHEMOTHERAPY
;
IMMUNOTHERAPY
; or
RADIATION
.
Terms
Toxic Optic Neuropathy
Preferred Term
Term UI
T000957389
Date
05/09/2019
LexicalTag
NON
ThesaurusID
NLM (2020)
Ocular Toxicity
Related
Concept UI
M000649535
Terms
Ocular Toxicity
Preferred Term
Term UI
T000957392
Date
05/09/2019
LexicalTag
NON
ThesaurusID
NLM (2020)
page delivered in 0.192s